Punit Srivastava – Mediception Science Pvt Ltd
View Detailed Executive Profile →Professional Overview
- Punit Srivastava co-founded MediCeption Science Pvt Ltd in January 2018, contributing to the establishment of a company focused on clinical, regulatory, and medical research.
- As the Chief Scientific Officer (CSO) at MediCeption from January 2016, Punit Srivastava played a critical role in advancing the company's research initiatives and regulatory strategies.
- In August 2018, Punit transitioned to the role of Director of Clinical, Regulatory & Medical Research, further enhancing the organization's ability to navigate complex regulatory environments.
- Prior to founding MediCeption, Punit held the position of Assistant Director at Daiichi Sankyo, Inc. from July 2010 to December 2016, where key achievements included leadership in project management and cross-functional team collaboration.
- Punit's earlier career included a significant tenure as Group Leader at Ranbaxy Research Laboratories from October 2004 to June 2010, where pivotal contributions were made towards the development of innovative pharmaceutical solutions.
- As a Senior Research Fellow at the University of Connecticut from April 2002 to August 2004, Punit advanced expertise in medical research methodologies and clinical trials.
- Punit Srivastava has been instrumental in driving MediCeption’s mission to bridge the gap between innovative science and regulatory compliance, ensuring the company’s projects align with industry standards.
- Throughout the career, Punit has faced challenges such as navigating complex regulatory frameworks and leading diverse research teams, demonstrating resilience and adaptability.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| Ranbaxy Research Laboratories | Group Leader | Oct 2004 – Jun 2010 |
| Daiichi Sankyo, Inc. | Asst Director | Jul 2010 – Dec 2016 |
| University of Connecticut | Senior Research Fellow | Apr 2002 – Aug 2004 |
| MediCeption Science Pvt Ltd | Co-Founder | Jan 2018 – Present |
| MediCeption Science Pvt Ltd | CSO - Clinical, Regulatory & Medical Research | Jan 2016 – Present |
| MediCeption Science Pvt Ltd | Director -Clinical, Regulatory & Medical Research | Aug 2018 – Present |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Mediception Science Pvt Ltd corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Punit Srivastava's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Mediception Science Pvt Ltd's official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)